Another alternative to Viagra is expected to be available soon
in the European Market. The pill will be called Spedra and Avanafil is the active
ingredient. The medication, which is awaiting
marketing authorisation from the European Commission, has been given a
green light from the Committee for Medicinal Products for Human Use (CHMP).
A few people are wondering whether this alternative
medication for Erectile Dysfunction will be a valuable
option in the European market, since there are already two alternatives to
Viagra –namely, Levitra and Cialis. As with any medication, Avanafil can cause
side effects which include: headaches, indigestion and back pain. However, Avanafil
has got a distinctive characteristic that is appealing to some erectile
dysfunction patients: it is able to help achieve an erection in as little as 15
minutes.
The Food and Drug Administration (FDA) has just approved the medication under the name of Stendra but it is not yet being manufactured.
We expect that the manufacturer will want to launch this product as soon as possible so we may be in a position to prescribe this medication within the next few months.